ASH 2022 Conference Coverage


 

ASH 2022 Outcomes of Older Patients With Aplastic Anemia Treated With Frontline Anti-Thymocyte Globulin-Based Immunosuppressive Therapy

0 views
December 16, 2022
Comments 0
Login to view comments. Click here to Login